Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Vertex Pharmaceuticals

(

VRTX

) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 0.6%. By the end of trading, Vertex Pharmaceuticals rose $1.68 (2.5%) to $67.96 on light volume. Throughout the day, 1,556,334 shares of Vertex Pharmaceuticals exchanged hands as compared to its average daily volume of 2,605,500 shares. The stock ranged in a price between $66.75-$69.00 after having opened the day at $67.44 as compared to the previous trading day's close of $66.28. Other companies within the Health Care sector that increased today were:

Prima Biomed

(

PBMD

), up 38.9%,

Ariad Pharmaceuticals

(

ARIA

), up 35.7%,

ImmunoCellular Therapeutics

(

IMUC

), up 35.7% and

IntelliPharmaCeutics International

(

IPCI

), up 19.0%.

Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. Vertex Pharmaceuticals has a market cap of $15.5 billion and is part of the drugs industry. Shares are up 58.1% year to date as of the close of trading on Friday. Currently there are 12 analysts that rate Vertex Pharmaceuticals a buy, no analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates Vertex Pharmaceuticals as a

sell

. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing return on equity and weak operating cash flow.

On the negative front,

Mast Therapeutics

(

TST Recommends

MSTX

), down 38.6%,

OraSure Technologies

(

OSUR

), down 16.6%,

ERBA Diagnostics

(

ERB

), down 16.4% and

Bacterin International Holdings

(

BONE

), down 15.9% , were all laggards within the health care sector with

Agilent Technologies

(

A

) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care

(

RXD

).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null